Meaningful improvement in general health outcomes with Guselkumab treatment for psoriatic arthritis: Patient-Reported Outcomes Measurement Information System-29 results from a phase 3 study (Patient -- Patient-Centered Outcomes Research, 2022)

(untitled) - Orbai, A-M; Coates, LC; Deodhar, A; Helliwell, PS; Ritchlin, CT; Leibowitz, E; Kollmeier, AP; Hsia, EC; Xu, XL; Sheng, S; Jiang, Y; Liu, Y; et al.